Global Hormone Patch Market Growth 2026-2032
The global Hormone Patch market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Hormone Patch is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Hormone Patch is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Hormone Patch is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Hormone Patch players cover Mylan Pharmaceuticals Inc.(Viatris), Twirla, Novartis(HEXAL AG), Bayer Healthcare Pharmaceuticals, Noven, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Hormone Patch Industry Forecast? looks at past sales and reviews total world Hormone Patch sales in 2025, providing a comprehensive analysis by region and market sector of projected Hormone Patch sales for 2026 through 2032. With Hormone Patch sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hormone Patch industry.
This Insight Report provides a comprehensive analysis of the global Hormone Patch landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hormone Patch portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Hormone Patch market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hormone Patch and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hormone Patch.
This report presents a comprehensive overview, market shares, and growth opportunities of Hormone Patch market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for Hormone Patch is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Hormone Patch is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Hormone Patch is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Hormone Patch players cover Mylan Pharmaceuticals Inc.(Viatris), Twirla, Novartis(HEXAL AG), Bayer Healthcare Pharmaceuticals, Noven, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Hormone Patch Industry Forecast? looks at past sales and reviews total world Hormone Patch sales in 2025, providing a comprehensive analysis by region and market sector of projected Hormone Patch sales for 2026 through 2032. With Hormone Patch sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hormone Patch industry.
This Insight Report provides a comprehensive analysis of the global Hormone Patch landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hormone Patch portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Hormone Patch market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hormone Patch and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hormone Patch.
This report presents a comprehensive overview, market shares, and growth opportunities of Hormone Patch market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Contraceptive Patch
- Estradiol Patch
- Others
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Mylan Pharmaceuticals Inc.(Viatris)
- Twirla
- Novartis(HEXAL AG)
- Bayer Healthcare Pharmaceuticals
- Noven
- AbbVie
- Hisamitsu Pharmaceutical Co., Inc.
- Watson Pharmaceuticals
- Johnson & Johnson
- ANI Pharmaceuticals
- Zhejiang Yatai Pharmaceutical Company Ltd.
- What is the 10-year outlook for the global Hormone Patch market?
- What factors are driving Hormone Patch market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Hormone Patch market opportunities vary by end market size?
- How does Hormone Patch break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hormone Patch Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Hormone Patch by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Hormone Patch by Country/Region, 2021, 2025 & 2032
2.2 Hormone Patch Segment by Type
2.2.1 Contraceptive Patch
2.2.2 Estradiol Patch
2.2.3 Others
2.2.4 Hormone Patch Sales by Type
2.2.4.1 Global Hormone Patch Sales Market Share by Type (2021-2026)
2.2.4.2 Global Hormone Patch Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Hormone Patch Sale Price by Type (2021-2026)
2.3 Hormone Patch Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Hormone Patch Sales by Application
2.3.3.1 Global Hormone Patch Sale Market Share by Application (2021-2026)
2.3.3.2 Global Hormone Patch Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Hormone Patch Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Hormone Patch Breakdown Data by Company
3.1.1 Global Hormone Patch Annual Sales by Company (2021-2026)
3.1.2 Global Hormone Patch Sales Market Share by Company (2021-2026)
3.2 Global Hormone Patch Annual Revenue by Company (2021-2026)
3.2.1 Global Hormone Patch Revenue by Company (2021-2026)
3.2.2 Global Hormone Patch Revenue Market Share by Company (2021-2026)
3.3 Global Hormone Patch Sale Price by Company
3.4 Key Manufacturers Hormone Patch Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hormone Patch Product Location Distribution
3.4.2 Players Hormone Patch Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HORMONE PATCH BY GEOGRAPHIC REGION
4.1 World Historic Hormone Patch Market Size by Geographic Region (2021-2026)
4.1.1 Global Hormone Patch Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Hormone Patch Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Hormone Patch Market Size by Country/Region (2021-2026)
4.2.1 Global Hormone Patch Annual Sales by Country/Region (2021-2026)
4.2.2 Global Hormone Patch Annual Revenue by Country/Region (2021-2026)
4.3 Americas Hormone Patch Sales Growth
4.4 APAC Hormone Patch Sales Growth
4.5 Europe Hormone Patch Sales Growth
4.6 Middle East & Africa Hormone Patch Sales Growth
5 AMERICAS
5.1 Americas Hormone Patch Sales by Country
5.1.1 Americas Hormone Patch Sales by Country (2021-2026)
5.1.2 Americas Hormone Patch Revenue by Country (2021-2026)
5.2 Americas Hormone Patch Sales by Type (2021-2026)
5.3 Americas Hormone Patch Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hormone Patch Sales by Region
6.1.1 APAC Hormone Patch Sales by Region (2021-2026)
6.1.2 APAC Hormone Patch Revenue by Region (2021-2026)
6.2 APAC Hormone Patch Sales by Type (2021-2026)
6.3 APAC Hormone Patch Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hormone Patch by Country
7.1.1 Europe Hormone Patch Sales by Country (2021-2026)
7.1.2 Europe Hormone Patch Revenue by Country (2021-2026)
7.2 Europe Hormone Patch Sales by Type (2021-2026)
7.3 Europe Hormone Patch Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hormone Patch by Country
8.1.1 Middle East & Africa Hormone Patch Sales by Country (2021-2026)
8.1.2 Middle East & Africa Hormone Patch Revenue by Country (2021-2026)
8.2 Middle East & Africa Hormone Patch Sales by Type (2021-2026)
8.3 Middle East & Africa Hormone Patch Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hormone Patch
10.3 Manufacturing Process Analysis of Hormone Patch
10.4 Industry Chain Structure of Hormone Patch
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hormone Patch Distributors
11.3 Hormone Patch Customer
12 WORLD FORECAST REVIEW FOR HORMONE PATCH BY GEOGRAPHIC REGION
12.1 Global Hormone Patch Market Size Forecast by Region
12.1.1 Global Hormone Patch Forecast by Region (2027-2032)
12.1.2 Global Hormone Patch Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Hormone Patch Forecast by Type (2027-2032)
12.7 Global Hormone Patch Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Mylan Pharmaceuticals Inc.(Viatris)
13.1.1 Mylan Pharmaceuticals Inc.(Viatris) Company Information
13.1.2 Mylan Pharmaceuticals Inc.(Viatris) Hormone Patch Product Portfolios and Specifications
13.1.3 Mylan Pharmaceuticals Inc.(Viatris) Hormone Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Mylan Pharmaceuticals Inc.(Viatris) Main Business Overview
13.1.5 Mylan Pharmaceuticals Inc.(Viatris) Latest Developments
13.2 Twirla
13.2.1 Twirla Company Information
13.2.2 Twirla Hormone Patch Product Portfolios and Specifications
13.2.3 Twirla Hormone Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Twirla Main Business Overview
13.2.5 Twirla Latest Developments
13.3 Novartis(HEXAL AG)
13.3.1 Novartis(HEXAL AG) Company Information
13.3.2 Novartis(HEXAL AG) Hormone Patch Product Portfolios and Specifications
13.3.3 Novartis(HEXAL AG) Hormone Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Novartis(HEXAL AG) Main Business Overview
13.3.5 Novartis(HEXAL AG) Latest Developments
13.4 Bayer Healthcare Pharmaceuticals
13.4.1 Bayer Healthcare Pharmaceuticals Company Information
13.4.2 Bayer Healthcare Pharmaceuticals Hormone Patch Product Portfolios and Specifications
13.4.3 Bayer Healthcare Pharmaceuticals Hormone Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Bayer Healthcare Pharmaceuticals Main Business Overview
13.4.5 Bayer Healthcare Pharmaceuticals Latest Developments
13.5 Noven
13.5.1 Noven Company Information
13.5.2 Noven Hormone Patch Product Portfolios and Specifications
13.5.3 Noven Hormone Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Noven Main Business Overview
13.5.5 Noven Latest Developments
13.6 AbbVie
13.6.1 AbbVie Company Information
13.6.2 AbbVie Hormone Patch Product Portfolios and Specifications
13.6.3 AbbVie Hormone Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 AbbVie Main Business Overview
13.6.5 AbbVie Latest Developments
13.7 Hisamitsu Pharmaceutical Co., Inc.
13.7.1 Hisamitsu Pharmaceutical Co., Inc. Company Information
13.7.2 Hisamitsu Pharmaceutical Co., Inc. Hormone Patch Product Portfolios and Specifications
13.7.3 Hisamitsu Pharmaceutical Co., Inc. Hormone Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Hisamitsu Pharmaceutical Co., Inc. Main Business Overview
13.7.5 Hisamitsu Pharmaceutical Co., Inc. Latest Developments
13.8 Watson Pharmaceuticals
13.8.1 Watson Pharmaceuticals Company Information
13.8.2 Watson Pharmaceuticals Hormone Patch Product Portfolios and Specifications
13.8.3 Watson Pharmaceuticals Hormone Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Watson Pharmaceuticals Main Business Overview
13.8.5 Watson Pharmaceuticals Latest Developments
13.9 Johnson & Johnson
13.9.1 Johnson & Johnson Company Information
13.9.2 Johnson & Johnson Hormone Patch Product Portfolios and Specifications
13.9.3 Johnson & Johnson Hormone Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Johnson & Johnson Main Business Overview
13.9.5 Johnson & Johnson Latest Developments
13.10 ANI Pharmaceuticals
13.10.1 ANI Pharmaceuticals Company Information
13.10.2 ANI Pharmaceuticals Hormone Patch Product Portfolios and Specifications
13.10.3 ANI Pharmaceuticals Hormone Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 ANI Pharmaceuticals Main Business Overview
13.10.5 ANI Pharmaceuticals Latest Developments
13.11 Zhejiang Yatai Pharmaceutical Company Ltd.
13.11.1 Zhejiang Yatai Pharmaceutical Company Ltd. Company Information
13.11.2 Zhejiang Yatai Pharmaceutical Company Ltd. Hormone Patch Product Portfolios and Specifications
13.11.3 Zhejiang Yatai Pharmaceutical Company Ltd. Hormone Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Zhejiang Yatai Pharmaceutical Company Ltd. Main Business Overview
13.11.5 Zhejiang Yatai Pharmaceutical Company Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hormone Patch Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Hormone Patch by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Hormone Patch by Country/Region, 2021, 2025 & 2032
2.2 Hormone Patch Segment by Type
2.2.1 Contraceptive Patch
2.2.2 Estradiol Patch
2.2.3 Others
2.2.4 Hormone Patch Sales by Type
2.2.4.1 Global Hormone Patch Sales Market Share by Type (2021-2026)
2.2.4.2 Global Hormone Patch Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Hormone Patch Sale Price by Type (2021-2026)
2.3 Hormone Patch Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Hormone Patch Sales by Application
2.3.3.1 Global Hormone Patch Sale Market Share by Application (2021-2026)
2.3.3.2 Global Hormone Patch Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Hormone Patch Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Hormone Patch Breakdown Data by Company
3.1.1 Global Hormone Patch Annual Sales by Company (2021-2026)
3.1.2 Global Hormone Patch Sales Market Share by Company (2021-2026)
3.2 Global Hormone Patch Annual Revenue by Company (2021-2026)
3.2.1 Global Hormone Patch Revenue by Company (2021-2026)
3.2.2 Global Hormone Patch Revenue Market Share by Company (2021-2026)
3.3 Global Hormone Patch Sale Price by Company
3.4 Key Manufacturers Hormone Patch Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hormone Patch Product Location Distribution
3.4.2 Players Hormone Patch Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HORMONE PATCH BY GEOGRAPHIC REGION
4.1 World Historic Hormone Patch Market Size by Geographic Region (2021-2026)
4.1.1 Global Hormone Patch Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Hormone Patch Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Hormone Patch Market Size by Country/Region (2021-2026)
4.2.1 Global Hormone Patch Annual Sales by Country/Region (2021-2026)
4.2.2 Global Hormone Patch Annual Revenue by Country/Region (2021-2026)
4.3 Americas Hormone Patch Sales Growth
4.4 APAC Hormone Patch Sales Growth
4.5 Europe Hormone Patch Sales Growth
4.6 Middle East & Africa Hormone Patch Sales Growth
5 AMERICAS
5.1 Americas Hormone Patch Sales by Country
5.1.1 Americas Hormone Patch Sales by Country (2021-2026)
5.1.2 Americas Hormone Patch Revenue by Country (2021-2026)
5.2 Americas Hormone Patch Sales by Type (2021-2026)
5.3 Americas Hormone Patch Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hormone Patch Sales by Region
6.1.1 APAC Hormone Patch Sales by Region (2021-2026)
6.1.2 APAC Hormone Patch Revenue by Region (2021-2026)
6.2 APAC Hormone Patch Sales by Type (2021-2026)
6.3 APAC Hormone Patch Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hormone Patch by Country
7.1.1 Europe Hormone Patch Sales by Country (2021-2026)
7.1.2 Europe Hormone Patch Revenue by Country (2021-2026)
7.2 Europe Hormone Patch Sales by Type (2021-2026)
7.3 Europe Hormone Patch Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hormone Patch by Country
8.1.1 Middle East & Africa Hormone Patch Sales by Country (2021-2026)
8.1.2 Middle East & Africa Hormone Patch Revenue by Country (2021-2026)
8.2 Middle East & Africa Hormone Patch Sales by Type (2021-2026)
8.3 Middle East & Africa Hormone Patch Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hormone Patch
10.3 Manufacturing Process Analysis of Hormone Patch
10.4 Industry Chain Structure of Hormone Patch
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hormone Patch Distributors
11.3 Hormone Patch Customer
12 WORLD FORECAST REVIEW FOR HORMONE PATCH BY GEOGRAPHIC REGION
12.1 Global Hormone Patch Market Size Forecast by Region
12.1.1 Global Hormone Patch Forecast by Region (2027-2032)
12.1.2 Global Hormone Patch Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Hormone Patch Forecast by Type (2027-2032)
12.7 Global Hormone Patch Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Mylan Pharmaceuticals Inc.(Viatris)
13.1.1 Mylan Pharmaceuticals Inc.(Viatris) Company Information
13.1.2 Mylan Pharmaceuticals Inc.(Viatris) Hormone Patch Product Portfolios and Specifications
13.1.3 Mylan Pharmaceuticals Inc.(Viatris) Hormone Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Mylan Pharmaceuticals Inc.(Viatris) Main Business Overview
13.1.5 Mylan Pharmaceuticals Inc.(Viatris) Latest Developments
13.2 Twirla
13.2.1 Twirla Company Information
13.2.2 Twirla Hormone Patch Product Portfolios and Specifications
13.2.3 Twirla Hormone Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Twirla Main Business Overview
13.2.5 Twirla Latest Developments
13.3 Novartis(HEXAL AG)
13.3.1 Novartis(HEXAL AG) Company Information
13.3.2 Novartis(HEXAL AG) Hormone Patch Product Portfolios and Specifications
13.3.3 Novartis(HEXAL AG) Hormone Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Novartis(HEXAL AG) Main Business Overview
13.3.5 Novartis(HEXAL AG) Latest Developments
13.4 Bayer Healthcare Pharmaceuticals
13.4.1 Bayer Healthcare Pharmaceuticals Company Information
13.4.2 Bayer Healthcare Pharmaceuticals Hormone Patch Product Portfolios and Specifications
13.4.3 Bayer Healthcare Pharmaceuticals Hormone Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Bayer Healthcare Pharmaceuticals Main Business Overview
13.4.5 Bayer Healthcare Pharmaceuticals Latest Developments
13.5 Noven
13.5.1 Noven Company Information
13.5.2 Noven Hormone Patch Product Portfolios and Specifications
13.5.3 Noven Hormone Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Noven Main Business Overview
13.5.5 Noven Latest Developments
13.6 AbbVie
13.6.1 AbbVie Company Information
13.6.2 AbbVie Hormone Patch Product Portfolios and Specifications
13.6.3 AbbVie Hormone Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 AbbVie Main Business Overview
13.6.5 AbbVie Latest Developments
13.7 Hisamitsu Pharmaceutical Co., Inc.
13.7.1 Hisamitsu Pharmaceutical Co., Inc. Company Information
13.7.2 Hisamitsu Pharmaceutical Co., Inc. Hormone Patch Product Portfolios and Specifications
13.7.3 Hisamitsu Pharmaceutical Co., Inc. Hormone Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Hisamitsu Pharmaceutical Co., Inc. Main Business Overview
13.7.5 Hisamitsu Pharmaceutical Co., Inc. Latest Developments
13.8 Watson Pharmaceuticals
13.8.1 Watson Pharmaceuticals Company Information
13.8.2 Watson Pharmaceuticals Hormone Patch Product Portfolios and Specifications
13.8.3 Watson Pharmaceuticals Hormone Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Watson Pharmaceuticals Main Business Overview
13.8.5 Watson Pharmaceuticals Latest Developments
13.9 Johnson & Johnson
13.9.1 Johnson & Johnson Company Information
13.9.2 Johnson & Johnson Hormone Patch Product Portfolios and Specifications
13.9.3 Johnson & Johnson Hormone Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Johnson & Johnson Main Business Overview
13.9.5 Johnson & Johnson Latest Developments
13.10 ANI Pharmaceuticals
13.10.1 ANI Pharmaceuticals Company Information
13.10.2 ANI Pharmaceuticals Hormone Patch Product Portfolios and Specifications
13.10.3 ANI Pharmaceuticals Hormone Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 ANI Pharmaceuticals Main Business Overview
13.10.5 ANI Pharmaceuticals Latest Developments
13.11 Zhejiang Yatai Pharmaceutical Company Ltd.
13.11.1 Zhejiang Yatai Pharmaceutical Company Ltd. Company Information
13.11.2 Zhejiang Yatai Pharmaceutical Company Ltd. Hormone Patch Product Portfolios and Specifications
13.11.3 Zhejiang Yatai Pharmaceutical Company Ltd. Hormone Patch Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Zhejiang Yatai Pharmaceutical Company Ltd. Main Business Overview
13.11.5 Zhejiang Yatai Pharmaceutical Company Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Hormone Patch Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Hormone Patch Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Contraceptive Patch
Table 4. Major Players of Estradiol Patch
Table 5. Major Players of Others
Table 6. Global Hormone Patch Sales by Type (2021-2026) & (K Units)
Table 7. Global Hormone Patch Sales Market Share by Type (2021-2026)
Table 8. Global Hormone Patch Revenue by Type (2021-2026) & ($ million)
Table 9. Global Hormone Patch Revenue Market Share by Type (2021-2026)
Table 10. Global Hormone Patch Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Hormone Patch Sale by Application (2021-2026) & (K Units)
Table 12. Global Hormone Patch Sale Market Share by Application (2021-2026)
Table 13. Global Hormone Patch Revenue by Application (2021-2026) & ($ million)
Table 14. Global Hormone Patch Revenue Market Share by Application (2021-2026)
Table 15. Global Hormone Patch Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Hormone Patch Sales by Company (2021-2026) & (K Units)
Table 17. Global Hormone Patch Sales Market Share by Company (2021-2026)
Table 18. Global Hormone Patch Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Hormone Patch Revenue Market Share by Company (2021-2026)
Table 20. Global Hormone Patch Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Hormone Patch Producing Area Distribution and Sales Area
Table 22. Players Hormone Patch Products Offered
Table 23. Hormone Patch Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Hormone Patch Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Hormone Patch Sales Market Share Geographic Region (2021-2026)
Table 28. Global Hormone Patch Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Hormone Patch Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Hormone Patch Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Hormone Patch Sales Market Share by Country/Region (2021-2026)
Table 32. Global Hormone Patch Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Hormone Patch Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Hormone Patch Sales by Country (2021-2026) & (K Units)
Table 35. Americas Hormone Patch Sales Market Share by Country (2021-2026)
Table 36. Americas Hormone Patch Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Hormone Patch Sales by Type (2021-2026) & (K Units)
Table 38. Americas Hormone Patch Sales by Application (2021-2026) & (K Units)
Table 39. APAC Hormone Patch Sales by Region (2021-2026) & (K Units)
Table 40. APAC Hormone Patch Sales Market Share by Region (2021-2026)
Table 41. APAC Hormone Patch Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Hormone Patch Sales by Type (2021-2026) & (K Units)
Table 43. APAC Hormone Patch Sales by Application (2021-2026) & (K Units)
Table 44. Europe Hormone Patch Sales by Country (2021-2026) & (K Units)
Table 45. Europe Hormone Patch Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Hormone Patch Sales by Type (2021-2026) & (K Units)
Table 47. Europe Hormone Patch Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Hormone Patch Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Hormone Patch Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Hormone Patch Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Hormone Patch Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Hormone Patch
Table 53. Key Market Challenges & Risks of Hormone Patch
Table 54. Key Industry Trends of Hormone Patch
Table 55. Hormone Patch Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Hormone Patch Distributors List
Table 58. Hormone Patch Customer List
Table 59. Global Hormone Patch Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Hormone Patch Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Hormone Patch Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Hormone Patch Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Hormone Patch Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Hormone Patch Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Hormone Patch Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Hormone Patch Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Hormone Patch Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Hormone Patch Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Hormone Patch Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Hormone Patch Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Hormone Patch Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Hormone Patch Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Mylan Pharmaceuticals Inc.(Viatris) Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 74. Mylan Pharmaceuticals Inc.(Viatris) Hormone Patch Product Portfolios and Specifications
Table 75. Mylan Pharmaceuticals Inc.(Viatris) Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Mylan Pharmaceuticals Inc.(Viatris) Main Business
Table 77. Mylan Pharmaceuticals Inc.(Viatris) Latest Developments
Table 78. Twirla Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 79. Twirla Hormone Patch Product Portfolios and Specifications
Table 80. Twirla Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Twirla Main Business
Table 82. Twirla Latest Developments
Table 83. Novartis(HEXAL AG) Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 84. Novartis(HEXAL AG) Hormone Patch Product Portfolios and Specifications
Table 85. Novartis(HEXAL AG) Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Novartis(HEXAL AG) Main Business
Table 87. Novartis(HEXAL AG) Latest Developments
Table 88. Bayer Healthcare Pharmaceuticals Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 89. Bayer Healthcare Pharmaceuticals Hormone Patch Product Portfolios and Specifications
Table 90. Bayer Healthcare Pharmaceuticals Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Bayer Healthcare Pharmaceuticals Main Business
Table 92. Bayer Healthcare Pharmaceuticals Latest Developments
Table 93. Noven Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 94. Noven Hormone Patch Product Portfolios and Specifications
Table 95. Noven Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Noven Main Business
Table 97. Noven Latest Developments
Table 98. AbbVie Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 99. AbbVie Hormone Patch Product Portfolios and Specifications
Table 100. AbbVie Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. AbbVie Main Business
Table 102. AbbVie Latest Developments
Table 103. Hisamitsu Pharmaceutical Co., Inc. Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 104. Hisamitsu Pharmaceutical Co., Inc. Hormone Patch Product Portfolios and Specifications
Table 105. Hisamitsu Pharmaceutical Co., Inc. Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Hisamitsu Pharmaceutical Co., Inc. Main Business
Table 107. Hisamitsu Pharmaceutical Co., Inc. Latest Developments
Table 108. Watson Pharmaceuticals Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 109. Watson Pharmaceuticals Hormone Patch Product Portfolios and Specifications
Table 110. Watson Pharmaceuticals Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Watson Pharmaceuticals Main Business
Table 112. Watson Pharmaceuticals Latest Developments
Table 113. Johnson & Johnson Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 114. Johnson & Johnson Hormone Patch Product Portfolios and Specifications
Table 115. Johnson & Johnson Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Johnson & Johnson Main Business
Table 117. Johnson & Johnson Latest Developments
Table 118. ANI Pharmaceuticals Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 119. ANI Pharmaceuticals Hormone Patch Product Portfolios and Specifications
Table 120. ANI Pharmaceuticals Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. ANI Pharmaceuticals Main Business
Table 122. ANI Pharmaceuticals Latest Developments
Table 123. Zhejiang Yatai Pharmaceutical Company Ltd. Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 124. Zhejiang Yatai Pharmaceutical Company Ltd. Hormone Patch Product Portfolios and Specifications
Table 125. Zhejiang Yatai Pharmaceutical Company Ltd. Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Zhejiang Yatai Pharmaceutical Company Ltd. Main Business
Table 127. Zhejiang Yatai Pharmaceutical Company Ltd. Latest Developments
Table 1. Hormone Patch Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Hormone Patch Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Contraceptive Patch
Table 4. Major Players of Estradiol Patch
Table 5. Major Players of Others
Table 6. Global Hormone Patch Sales by Type (2021-2026) & (K Units)
Table 7. Global Hormone Patch Sales Market Share by Type (2021-2026)
Table 8. Global Hormone Patch Revenue by Type (2021-2026) & ($ million)
Table 9. Global Hormone Patch Revenue Market Share by Type (2021-2026)
Table 10. Global Hormone Patch Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Hormone Patch Sale by Application (2021-2026) & (K Units)
Table 12. Global Hormone Patch Sale Market Share by Application (2021-2026)
Table 13. Global Hormone Patch Revenue by Application (2021-2026) & ($ million)
Table 14. Global Hormone Patch Revenue Market Share by Application (2021-2026)
Table 15. Global Hormone Patch Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Hormone Patch Sales by Company (2021-2026) & (K Units)
Table 17. Global Hormone Patch Sales Market Share by Company (2021-2026)
Table 18. Global Hormone Patch Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Hormone Patch Revenue Market Share by Company (2021-2026)
Table 20. Global Hormone Patch Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Hormone Patch Producing Area Distribution and Sales Area
Table 22. Players Hormone Patch Products Offered
Table 23. Hormone Patch Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Hormone Patch Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Hormone Patch Sales Market Share Geographic Region (2021-2026)
Table 28. Global Hormone Patch Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Hormone Patch Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Hormone Patch Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Hormone Patch Sales Market Share by Country/Region (2021-2026)
Table 32. Global Hormone Patch Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Hormone Patch Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Hormone Patch Sales by Country (2021-2026) & (K Units)
Table 35. Americas Hormone Patch Sales Market Share by Country (2021-2026)
Table 36. Americas Hormone Patch Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Hormone Patch Sales by Type (2021-2026) & (K Units)
Table 38. Americas Hormone Patch Sales by Application (2021-2026) & (K Units)
Table 39. APAC Hormone Patch Sales by Region (2021-2026) & (K Units)
Table 40. APAC Hormone Patch Sales Market Share by Region (2021-2026)
Table 41. APAC Hormone Patch Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Hormone Patch Sales by Type (2021-2026) & (K Units)
Table 43. APAC Hormone Patch Sales by Application (2021-2026) & (K Units)
Table 44. Europe Hormone Patch Sales by Country (2021-2026) & (K Units)
Table 45. Europe Hormone Patch Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Hormone Patch Sales by Type (2021-2026) & (K Units)
Table 47. Europe Hormone Patch Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Hormone Patch Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Hormone Patch Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Hormone Patch Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Hormone Patch Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Hormone Patch
Table 53. Key Market Challenges & Risks of Hormone Patch
Table 54. Key Industry Trends of Hormone Patch
Table 55. Hormone Patch Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Hormone Patch Distributors List
Table 58. Hormone Patch Customer List
Table 59. Global Hormone Patch Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Hormone Patch Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Hormone Patch Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Hormone Patch Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Hormone Patch Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Hormone Patch Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Hormone Patch Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Hormone Patch Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Hormone Patch Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Hormone Patch Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Hormone Patch Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Hormone Patch Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Hormone Patch Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Hormone Patch Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Mylan Pharmaceuticals Inc.(Viatris) Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 74. Mylan Pharmaceuticals Inc.(Viatris) Hormone Patch Product Portfolios and Specifications
Table 75. Mylan Pharmaceuticals Inc.(Viatris) Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Mylan Pharmaceuticals Inc.(Viatris) Main Business
Table 77. Mylan Pharmaceuticals Inc.(Viatris) Latest Developments
Table 78. Twirla Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 79. Twirla Hormone Patch Product Portfolios and Specifications
Table 80. Twirla Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Twirla Main Business
Table 82. Twirla Latest Developments
Table 83. Novartis(HEXAL AG) Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 84. Novartis(HEXAL AG) Hormone Patch Product Portfolios and Specifications
Table 85. Novartis(HEXAL AG) Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Novartis(HEXAL AG) Main Business
Table 87. Novartis(HEXAL AG) Latest Developments
Table 88. Bayer Healthcare Pharmaceuticals Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 89. Bayer Healthcare Pharmaceuticals Hormone Patch Product Portfolios and Specifications
Table 90. Bayer Healthcare Pharmaceuticals Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Bayer Healthcare Pharmaceuticals Main Business
Table 92. Bayer Healthcare Pharmaceuticals Latest Developments
Table 93. Noven Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 94. Noven Hormone Patch Product Portfolios and Specifications
Table 95. Noven Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Noven Main Business
Table 97. Noven Latest Developments
Table 98. AbbVie Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 99. AbbVie Hormone Patch Product Portfolios and Specifications
Table 100. AbbVie Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. AbbVie Main Business
Table 102. AbbVie Latest Developments
Table 103. Hisamitsu Pharmaceutical Co., Inc. Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 104. Hisamitsu Pharmaceutical Co., Inc. Hormone Patch Product Portfolios and Specifications
Table 105. Hisamitsu Pharmaceutical Co., Inc. Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Hisamitsu Pharmaceutical Co., Inc. Main Business
Table 107. Hisamitsu Pharmaceutical Co., Inc. Latest Developments
Table 108. Watson Pharmaceuticals Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 109. Watson Pharmaceuticals Hormone Patch Product Portfolios and Specifications
Table 110. Watson Pharmaceuticals Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Watson Pharmaceuticals Main Business
Table 112. Watson Pharmaceuticals Latest Developments
Table 113. Johnson & Johnson Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 114. Johnson & Johnson Hormone Patch Product Portfolios and Specifications
Table 115. Johnson & Johnson Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Johnson & Johnson Main Business
Table 117. Johnson & Johnson Latest Developments
Table 118. ANI Pharmaceuticals Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 119. ANI Pharmaceuticals Hormone Patch Product Portfolios and Specifications
Table 120. ANI Pharmaceuticals Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. ANI Pharmaceuticals Main Business
Table 122. ANI Pharmaceuticals Latest Developments
Table 123. Zhejiang Yatai Pharmaceutical Company Ltd. Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 124. Zhejiang Yatai Pharmaceutical Company Ltd. Hormone Patch Product Portfolios and Specifications
Table 125. Zhejiang Yatai Pharmaceutical Company Ltd. Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Zhejiang Yatai Pharmaceutical Company Ltd. Main Business
Table 127. Zhejiang Yatai Pharmaceutical Company Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Hormone Patch
Figure 2. Hormone Patch Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hormone Patch Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Hormone Patch Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Hormone Patch Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Hormone Patch Sales Market Share by Country/Region (2025)
Figure 10. Hormone Patch Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Contraceptive Patch
Figure 12. Product Picture of Estradiol Patch
Figure 13. Product Picture of Others
Figure 14. Global Hormone Patch Sales Market Share by Type in 2026
Figure 15. Global Hormone Patch Revenue Market Share by Type (2021-2026)
Figure 16. Hormone Patch Consumed in Hospital
Figure 17. Global Hormone Patch Market: Hospital (2021-2026) & (K Units)
Figure 18. Hormone Patch Consumed in Clinic
Figure 19. Global Hormone Patch Market: Clinic (2021-2026) & (K Units)
Figure 20. Global Hormone Patch Sale Market Share by Application (2025)
Figure 21. Global Hormone Patch Revenue Market Share by Application in 2026
Figure 22. Hormone Patch Sales by Company in 2026 (K Units)
Figure 23. Global Hormone Patch Sales Market Share by Company in 2026
Figure 24. Hormone Patch Revenue by Company in 2026 ($ millions)
Figure 25. Global Hormone Patch Revenue Market Share by Company in 2026
Figure 26. Global Hormone Patch Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Hormone Patch Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Hormone Patch Sales 2021-2026 (K Units)
Figure 29. Americas Hormone Patch Revenue 2021-2026 ($ millions)
Figure 30. APAC Hormone Patch Sales 2021-2026 (K Units)
Figure 31. APAC Hormone Patch Revenue 2021-2026 ($ millions)
Figure 32. Europe Hormone Patch Sales 2021-2026 (K Units)
Figure 33. Europe Hormone Patch Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Hormone Patch Sales 2021-2026 (K Units)
Figure 35. Middle East & Africa Hormone Patch Revenue 2021-2026 ($ millions)
Figure 36. Americas Hormone Patch Sales Market Share by Country in 2026
Figure 37. Americas Hormone Patch Revenue Market Share by Country (2021-2026)
Figure 38. Americas Hormone Patch Sales Market Share by Type (2021-2026)
Figure 39. Americas Hormone Patch Sales Market Share by Application (2021-2026)
Figure 40. United States Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Hormone Patch Sales Market Share by Region in 2026
Figure 45. APAC Hormone Patch Revenue Market Share by Region (2021-2026)
Figure 46. APAC Hormone Patch Sales Market Share by Type (2021-2026)
Figure 47. APAC Hormone Patch Sales Market Share by Application (2021-2026)
Figure 48. China Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 52. India Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Hormone Patch Sales Market Share by Country in 2026
Figure 56. Europe Hormone Patch Revenue Market Share by Country (2021-2026)
Figure 57. Europe Hormone Patch Sales Market Share by Type (2021-2026)
Figure 58. Europe Hormone Patch Sales Market Share by Application (2021-2026)
Figure 59. Germany Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 60. France Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Hormone Patch Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Hormone Patch Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Hormone Patch Sales Market Share by Application (2021-2026)
Figure 67. Egypt Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Hormone Patch in 2026
Figure 73. Manufacturing Process Analysis of Hormone Patch
Figure 74. Industry Chain Structure of Hormone Patch
Figure 75. Channels of Distribution
Figure 76. Global Hormone Patch Sales Market Forecast by Region (2027-2032)
Figure 77. Global Hormone Patch Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Hormone Patch Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Hormone Patch Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Hormone Patch Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Hormone Patch Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Hormone Patch
Figure 2. Hormone Patch Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hormone Patch Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Hormone Patch Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Hormone Patch Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Hormone Patch Sales Market Share by Country/Region (2025)
Figure 10. Hormone Patch Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Contraceptive Patch
Figure 12. Product Picture of Estradiol Patch
Figure 13. Product Picture of Others
Figure 14. Global Hormone Patch Sales Market Share by Type in 2026
Figure 15. Global Hormone Patch Revenue Market Share by Type (2021-2026)
Figure 16. Hormone Patch Consumed in Hospital
Figure 17. Global Hormone Patch Market: Hospital (2021-2026) & (K Units)
Figure 18. Hormone Patch Consumed in Clinic
Figure 19. Global Hormone Patch Market: Clinic (2021-2026) & (K Units)
Figure 20. Global Hormone Patch Sale Market Share by Application (2025)
Figure 21. Global Hormone Patch Revenue Market Share by Application in 2026
Figure 22. Hormone Patch Sales by Company in 2026 (K Units)
Figure 23. Global Hormone Patch Sales Market Share by Company in 2026
Figure 24. Hormone Patch Revenue by Company in 2026 ($ millions)
Figure 25. Global Hormone Patch Revenue Market Share by Company in 2026
Figure 26. Global Hormone Patch Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Hormone Patch Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Hormone Patch Sales 2021-2026 (K Units)
Figure 29. Americas Hormone Patch Revenue 2021-2026 ($ millions)
Figure 30. APAC Hormone Patch Sales 2021-2026 (K Units)
Figure 31. APAC Hormone Patch Revenue 2021-2026 ($ millions)
Figure 32. Europe Hormone Patch Sales 2021-2026 (K Units)
Figure 33. Europe Hormone Patch Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Hormone Patch Sales 2021-2026 (K Units)
Figure 35. Middle East & Africa Hormone Patch Revenue 2021-2026 ($ millions)
Figure 36. Americas Hormone Patch Sales Market Share by Country in 2026
Figure 37. Americas Hormone Patch Revenue Market Share by Country (2021-2026)
Figure 38. Americas Hormone Patch Sales Market Share by Type (2021-2026)
Figure 39. Americas Hormone Patch Sales Market Share by Application (2021-2026)
Figure 40. United States Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Hormone Patch Sales Market Share by Region in 2026
Figure 45. APAC Hormone Patch Revenue Market Share by Region (2021-2026)
Figure 46. APAC Hormone Patch Sales Market Share by Type (2021-2026)
Figure 47. APAC Hormone Patch Sales Market Share by Application (2021-2026)
Figure 48. China Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 52. India Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Hormone Patch Sales Market Share by Country in 2026
Figure 56. Europe Hormone Patch Revenue Market Share by Country (2021-2026)
Figure 57. Europe Hormone Patch Sales Market Share by Type (2021-2026)
Figure 58. Europe Hormone Patch Sales Market Share by Application (2021-2026)
Figure 59. Germany Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 60. France Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Hormone Patch Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Hormone Patch Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Hormone Patch Sales Market Share by Application (2021-2026)
Figure 67. Egypt Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Hormone Patch Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Hormone Patch in 2026
Figure 73. Manufacturing Process Analysis of Hormone Patch
Figure 74. Industry Chain Structure of Hormone Patch
Figure 75. Channels of Distribution
Figure 76. Global Hormone Patch Sales Market Forecast by Region (2027-2032)
Figure 77. Global Hormone Patch Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Hormone Patch Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Hormone Patch Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Hormone Patch Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Hormone Patch Revenue Market Share Forecast by Application (2027-2032)
